Health Care Technology
Company Overview of Theranos, Inc.
Theranos, Inc. operates as a consumer healthcare technology company. It specializes in the areas of oncology, pediatrics, and geriatrics. The company designs, develops, and manufactures systems that provide access to health information for the early detection and intervention of diseases; and conducts laboratory tests from blood, urine, fluid, solid, and other samples. It also provides a suite of tools for patients and doctors ranging from Websites to mobile applications. The company was founded in 2003 and is based in Palo Alto, California.
1601 South California Avenue
Palo Alto, CA 94304
Founded in 2003
Key Executives for Theranos, Inc.
Founder, Chairman and Chief Executive Officer
President, Chief Operating Officer and Director
Vice President of Finance & Operations
Compensation as of Fiscal Year 2015.
Theranos, Inc. Key Developments
Theranos, Inc. Receives U.S. Food and Drug Administration’s Clearance of its Test System and Test for Herpes Simplex 1 Virus IgG
Jul 2 15
Theranos, Inc. announced that it has received the U.S. Food and Drug Administration’s (FDA) clearance of its test system and test for herpes simplex 1 virus IgG. The FDA’s decision provides independent validation of Theranos’ patented finger stick and venous blood testing technology and the ground breaking Theranos System upon which the HSV-1 IgG test is run, as well as the approach that the company has supported for FDA review of Laboratory Developed Tests (LDTs). The FDA decision involved extensive review of the Theranos System. The FDA clearance includes the use of Theranos’ Nanotainer™ Tubes for tests run by this method, which allow samples to be collected from just a few drops of blood from a virtually painless prick of a patient’s finger. The Theranos System, including Theranos’ device, analytical software, and Nanotainer™ Tubes, has been fully validated and cleared for use with this test method. FDA’s review process for 510(k) notifications is widely recognized as one of the most rigorous regulatory hurdles in the world for evaluation of the performance, accuracy, and intended use of diagnostic tests. Today’s announcement demonstrates that Theranos has met that standard and is an important step in Theranos’ mission to make health information accessible to people at the time it matters, enabling early detection and prevention of disease, and empowering individuals everywhere with information to live healthier lives – a mission that depends on patients knowing they are getting results they can trust.
Theranos, Inc. Appoints Heather King as General Counsel
May 7 15
Theranos, Inc. announced that Heather King has been appointed as General Counsel. King has been a partner at Boies, Schiller & Flexner in their Washington, D.C. office and has worked closely with their client, Theranos. King, who will be moving to Palo Alto. Before joining Boies, Schiller & Flexner, King served as Special Assistant and Policy Advisor to U.S. Senator Hillary Rodham Clinton, and helped lead Senator Clinton’s campaigns.
Theranos, Inc. Appoints H. Foege as Director
Aug 5 14
Theranos, Inc. announced the appointment of William H. Foege, M.D., M.P.H., to its Board of Directors. Dr. Foege, an epidemiologist and former director of the U.S. Center for Disease Control and Prevention, has left an indelible mark on the field of global health. Recognized as the health innovator behind the successful campaign to eradicate smallpox in the 1970s, Dr. Foege received the Presidential Medal of Freedom in 2012, the nation's high civilian honor. He was a senior medical advisor for the Bill and Melinda Gates Foundation from 1999 until his retirement in 2011.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|